Inhibitor of proliferation of arterial smooth-muscle cells by fluvastatin
- 1 December 1996
- journal article
- Published by Elsevier in The Lancet
- Vol. 348 (9041), 1584
- https://doi.org/10.1016/s0140-6736(05)66196-x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pathogenesis of atherosclerosisand the role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitorsThe American Journal of Cardiology, 1995
- Baseline characteristics of subjects in the lipoprotein and coronary atherosclerosis study (LCAS) with fluvastatinThe American Journal of Cardiology, 1994
- Pharmacokinetics of Fluvastatin After Single and Multiple Doses in Normal VolunteersThe Journal of Clinical Pharmacology, 1992
- Posttranslational modification of proteins by isoprenoids in mammalian cellsThe FASEB Journal, 1990
- Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferationJournal of the American College of Cardiology, 1990